MyoKardia (MYOK) PT Raised to $87 at Morgan Stanley
Tweet
Share
E-mailGet Alerts MYOK Hot Sheet
Price: $224.91 --0%
Rating Summary:
4 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
4 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Morgan Stanley analyst Jeffrey Hung raised the price target on MyoKardia (NASDAQ: MYOK) to $87.00 (from $83.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Nissan Chemical (4021:JP) PT Raised to JPY8,300 at Nomura/Instinet
- Suntory Beverage & Food Ltd (2587:JP) (STBFY) PT Lowered to JPY4,600 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
